Can we predict which patients with refractory dyspnea will respond to opioids?

Journal of Palliative Medicine

Volumn 10, Issue 5, 2007, Pages 1031-1036

  Currow, David C ^a,b   Plummer, John ^a   Frith, Peter ^b   Abernethy, Amy P ^a,b,c  

^a FLINDERS UNIVERSITY   (Australia)

^b REPATRIATION GENERAL HOSPITAL   (Australia)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; OPIATE DERIVATIVE; PLACEBO;

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; CROSSOVER PROCEDURE; DYSPNEA; FEMALE; FORECASTING; FUNCTIONAL STATUS; HUMAN; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STUDENT T TEST; SUSTAINED RELEASE PREPARATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CROSS-OVER STUDIES; DYSPNEA; FEMALE; HEALTH STATUS INDICATORS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PILOT PROJECTS; PROGNOSIS; QUESTIONNAIRES; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 35948991057     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2007.9912     Document Type: Article

References (16)

1. Reuben DB, Mor V: Dyspnea in terminally ill cancer patients. Chest 1986;89:234-236.
2. Bruera E, Schmitz B, Pither J, Neumann CM, Hanson J: The frequency and correlates of dyspnea in patients with advanced cancer. J Pain Symptom Manage 2000;19:357-362.
3. Ripamonti C: Management of dyspnea in advanced cancer patients. Support Care Cancer 1999;7:233-243.
4. Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Bui C: Randomized, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnea. BMJ 2003;327:523-528.
5. Tanaka K, Akechi T, Okuyama T, Nishiwaki Y, Uchitomi Y: Prevalence and screening of dyspnea interfering with daily life activities in ambulatory patients with advanced lung cancer. J Pain Symptom Manage 2002;23:484-489.
6. Corner J, Plant H, A'Hern R, Bailey C: Non-pharmacological intervention for breathlessness in lung cancer. Palliat Med 1996;10:299-305.
7. Bredin M, Corner J, Krishnasamy M, Plant H, Bailey C, A'Hern R: Multi-center randomized controlled trial of nursing intervention for breathlessness in patients with lung cancer. BMJ 1999;318:901-904.
8. Ahmedzai S: Palliation of respiratory symptoms. In: Doyle D, Hanks G, MacDonald N, (eds.): Oxford Textbook of Palliative Medicine. Oxford: Oxford University Press, 1998, pp. 349-378.
9. Jennings AL, Davies AN, Higgins JP, Gibbs JS, Broadley KE: A systematic review of the use of opioids in the management of dyspnea. Thorax 2002;57:939-944.
10. Abramson MJ, Crockett AJ, Frith PA, McDonald CF: COPDX: An update of guidelines for the management of chronic obstructive pulmonary disease with a review of recent evidence. Med J Aust 2006;184:342-345.
11. Allen S, Raut S, Woollard J, Vassallo M: Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis. Palliat Med 2005;19:128-130.
12. Ganzini L, Johnston WS, Silveira MJ: The final month of life in patients with ALS. Neurology 2002;59:428-431.
13. Johnson MJ, McDonagh TA, Harkness A, McKay SE, Dargie HJ: Morphine for the relief of breathlessness in patients with chronic heart failure - A pilot study. Eur J Heart Fail 2002;4:753-756.
14. Navigante AH, Cerchietti LC, Castro MA, Lutteral MA, Cabalar ME: Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer. J Pain Symptom Manage 2006;31:38-47.
15. Allard P, Lamontagne C, Bernard P, Tremblay C: How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial. J Pain Symptom Manage 1999;17:256-265.
16. Berrill JW, Linnasne SJ: Morphine for management of refractory dyspnea: Opiates should be used with caution. BMJ 2003;327:1288.